Funder
London Metropolitan University, Quality-related research funding
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Health (social science)
Reference119 articles.
1. Agoff, S.N., et al. 2003. Androgen receptor expression in estrogen receptor-negative breast cancer immunohistochemical, clinical, and prognostic associations. American Journal of Clinical Pathology 120: 725–731.
2. Annandale, E., and A. Hammarström. 2010. Constructing the ‘gender-specific body’: A critical discourse analysis of publications in the field of gender-specific medicine. Health 15 (6): 571–587.
3. Anon, 1979. Consensus: Use of estrogen receptor assay. Journal of the American Medical Association 242 (16): 1714–1716.
4. Bakker, G.H., et al. 1987. Comparison of the actions of the antiprogestin mifepristone (RU 486), the progestin megestrol acetate, the LHRH analog buserelin, and ovariectomy in treatment of rat mammary tumors. Cancer Treatment Reports 71 (11): 1021–1027.
5. Bakker, G.H., et al. 1990. Treatment of breast cancer with different antiprogestins: Preclinical and clinical studies. Journal of Steroid Biochemistry and Molecular Biology 37: 789–794.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献